Chinese venture capital investment in US biotech falls as Washington tightens scrutiny of funding from overseas, German chemicals group BASF cuts its full-year forecast and warns that second-quarter profits would almost halve and Deutsche Bank begins the culling of 18,000 jobs, with whole teams of equity traders being dismissed. Plus, the FT’s US legal and enforcement correspondent, Kadhim Shubber, explains the sex trafficking charges against money manager Jeffrey Epstein.
Hosted on Acast. See acast.com/privacy for more information.
Fler avsnitt av FT News Briefing
Visa alla avsnitt av FT News BriefingFT News Briefing med Financial Times finns tillgänglig på flera plattformar. Informationen på denna sida kommer från offentliga podd-flöden.
